We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$66.4B
AUM Growth
+$5.93B
(+9.8%)
Cap. Flow
-$619M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
3,510
New
779
Increased
864
Reduced
1,015
Closed
774
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$500M |
| 2 |
Arista Networks
ANET
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$271M |
| 4 |
Eli Lilly
LLY
|
+$271M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$495M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$388M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$369M |
| 5 |
Mastercard
MA
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Consumer Discretionary | 9.99% |
| 3 | Financials | 9.73% |
| 4 | Industrials | 7.81% |
| 5 | Healthcare | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
CALL
Ultragenyx Pharmaceutical
RARE
$2.66B
| $6.73M | 0.01% |
185,000
-165,000
| -47% | -$5.95M |
|
1127
GFL Environmental
GFL
$14.9B
| $6.71M | 0.01% |
+133,037
| New | +$6.53M |
|
1128
Itron
ITRI
$4.52B
| $6.69M | 0.01% |
50,817
-370,204
| -88% | -$41.9M |
|
|
BCPC
1129
Balchem Corp
BCPC
$5.71B
| $6.68M | 0.01% |
41,962
+14,823
| +55% | +$2.4M |
|
1130
M/I Homes
MHO
$3.85B
| $6.68M | 0.01% |
59,540
-127,925
| -68% | -$13.9M |
|
1131
PUT
Under Armour
UAA
$2.29B
| $6.64M | 0.01% |
971,900
+806,900
| +489% | +$5.02M |
|
1132
Sphere Entertainment
SPHR
$5.83B
| $6.64M | 0.01% |
158,783
-537,446
| -77% | -$18.2M |
|
1133
PUT
CoStar Group
CSGP
$12.6B
| $6.63M | 0.01% |
+82,500
| New | +$6.43M |
|
1134
PUT
Chipotle Mexican Grill
CMG
$40.5B
| $6.61M | 0.01% |
117,800
-386,500
| -77% | -$19.7M |
|
1135
CALL
Pultegroup
PHM
$25.2B
| $6.59M | 0.01% |
62,500
| – | – |
|
1136
CrowdStrike
CRWD
$226B
| $6.58M | 0.01% |
51,696
-76,384
| -60% | -$8.28M |
|
1137
Alarm.com
ALRM
$2.77B
| $6.58M | 0.01% |
116,262
-12,627
| -10% | -$701K |
|
1138
Regenxbio
RGNX
$703M
| $6.54M | 0.01% |
797,100
-601,397
| -43% | -$5.03M |
|
1139
DuPont de Nemours
DD
$19.5B
| $6.54M | 0.01% |
76,008
-450,308
| -86% | -$37.4M |
|
1140
Lennar Class A
LEN
$21.1B
| $6.54M | 0.01% |
59,135
+29,780
| +101% | +$3.23M |
|
1141
Exponent
EXPO
$3.25B
| $6.54M | 0.01% |
87,496
+7,397
| +9% | +$573K |
|
1142
CALL
Marvell Technology
MRVL
$191B
| $6.53M | 0.01% |
84,400
+59,100
| +234% | +$3.69M |
|
1143
PUT
Sea Limited
SE
$80.5B
| $6.53M | 0.01% |
52,100
+6,100
| +13% | +$883K |
|
1144
Huazhu Hotels Group
HTHT
$12.8B
| $6.51M | 0.01% |
+191,943
| New | +$6.73M |
|
1145
PUT
SLB Ltd
SLB
$79.7B
| $6.51M | 0.01% |
192,600
-329,100
| -63% | -$11.4M |
|
1146
CytomX Therapeutics
CTMX
$752M
| $6.5M | 0.01% |
+2,865,625
| New | +$4.62M |
|
1147
CALL
CVS Health
CVS
$120B
| $6.5M | 0.01% |
94,300
+59,900
| +174% | +$3.93M |
|
1148
Groupon
GRPN
$889M
| $6.5M | 0.01% |
+194,256
| New | +$4.95M |
|
1149
CALL
Delta Air Lines
DAL
$59.5B
| $6.48M | 0.01% |
+131,800
| New | +$6.05M |
|
1150
British American Tobacco
BTI
$122B
| $6.47M | 0.01% |
136,690
+16,648
| +14% | +$737K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Balyasny Asset Management held 3,510 positions worth $66.4B, up 9.8% from $60.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Balyasny Asset Management's Q2 2025 filing shows 779 new, 864 increased, 1,015 reduced and 774 closed positions. Its largest new stake was Arista Networks: 3,646,977 shares worth $373M. The largest sale was iShares Core S&P 500 ETF, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
- Balyasny Asset Management's largest Q2 2025 buy was Arista Networks: 3,646,977 shares worth $373M.
- Balyasny Asset Management added most to Brown & Brown in Q2 2025, an estimated $500M increase.
- Balyasny Asset Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $495M.
- Balyasny Asset Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2025, selling an estimated $369M.
- Balyasny Asset Management's ten largest holdings make up 13% of its $66.4B portfolio in Q2 2025.
- Balyasny Asset Management opened 779 new positions and closed 774 in Q2 2025.
- Balyasny Asset Management's portfolio value rose 9.8% quarter-over-quarter to $66.4B.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.